scholarly article | Q13442814 |
P50 | author | Antonio Rescifina | Q40364172 |
Luca Vanella | Q46685758 | ||
Valeria Sorrenti | Q48139552 | ||
Agostino Marrazzo | Q55714836 | ||
Sebastiano Intagliata | Q57127107 | ||
Giuseppe Floresta | Q60992936 | ||
Khaled Greish | Q61158024 | ||
Valeria Pittalà | Q79207229 | ||
Loredana Salerno | Q87561855 | ||
P2093 | author name string | Valeria Ciaffaglione | |
Ameera Sultan | |||
P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1 | Q27021350 | ||
X-ray crystallographic and biochemical characterization of the inhibitory action of an imidazole-dioxolane compound on heme oxygenase | Q27643656 | ||
A Novel, “Double-Clamp” Binding Mode for Human Heme Oxygenase-1 Inhibition | Q27676882 | ||
Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications | Q28306266 | ||
JChem: Java Applets and Modules Supporting Chemical Database Handling from Web Browsers | Q28837141 | ||
The therapeutic potential of carbon monoxide | Q29036279 | ||
Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite | Q33828009 | ||
Generation of bile pigments by haem oxygenase: a refined cellular strategy in response to stressful insults. | Q36074194 | ||
Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds | Q36591335 | ||
Inducers of heme oxygenase-1. | Q37090270 | ||
MOPAC: a semiempirical molecular orbital program | Q37328051 | ||
Evidence that the heme regulatory motifs in heme oxygenase-2 serve as a thiol/disulfide redox switch regulating heme binding | Q37642980 | ||
Heme oxygenase-1: emerging target of cancer therapy | Q38426058 | ||
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors. | Q38679172 | ||
Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties. | Q39124032 | ||
HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation | Q39285687 | ||
Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions. | Q39376128 | ||
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors | Q42374355 | ||
A novel antifungal agent with broad spectrum: 1-(4-biphenylyl)-3-(1H-imidazol-1-yl)-1-propanone. | Q42713801 | ||
Synthesis and evaluation of azalanstat analogues as heme oxygenase inhibitors | Q45266887 | ||
Ejaculatory abnormalities in mice with targeted disruption of the gene for heme oxygenase-2. | Q48564673 | ||
Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors. | Q49902738 | ||
Novel Caffeic Acid Phenethyl Ester (Cape) Analogues as Inducers of Heme Oxygenase-1. | Q50897437 | ||
Sulforhodamine B colorimetric assay for cytotoxicity screening. | Q51032435 | ||
Heme oxygenase inhibition in cancers: possible tools and targets. | Q52431393 | ||
Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia. | Q53135203 | ||
Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines. | Q53803393 | ||
Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation | Q60503345 | ||
A Dual Role of Heme Oxygenase-1 in Cancer Cells | Q60939671 | ||
Potential Applications of NRF2 Inhibitors in Cancer Therapy | Q64056540 | ||
Ultrasound-promoted intramolecular direct arylation in a capillary flow microreactor | Q84797507 | ||
The inhibition of heme oxygenase-1 enhances the chemosensitivity and suppresses the proliferation of pancreatic cancer cells through the SHH signaling pathway | Q88274166 | ||
Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib | Q89287854 | ||
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors | Q90256692 | ||
Ginseng and heme oxygenase-1: The link between an old herb and a new protective system | Q90822550 | ||
Structural Insights into Azole-based Inhibitors of Heme Oxygenase-1: Development of Selective Compounds for Therapeutic Applications | Q91184348 | ||
Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment | Q91651958 | ||
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application | Q91740207 | ||
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines | Q91814108 | ||
Protective Effects of Caffeic Acid Phenethyl Ester (CAPE) and Novel Cape Analogue as Inducers of Heme Oxygenase-1 in Streptozotocin-Induced Type 1 Diabetic Rats | Q92162872 | ||
Targeting Heme Oxygenase-1 in Cardiovascular and Kidney Disease | Q92879564 | ||
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents | Q93008903 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P577 | publication date | 2020-03-11 | |
P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
P1476 | title | New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells | |
P478 | volume | 21 |
Search more.